• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[成本/效益关系:高血压治疗]

[Cost/benefit relations: therapy of hypertension].

作者信息

Rahn K H, Hohage H

机构信息

Medizinische Poliklinik, Westfälischen Wilhelms-Universität Münster.

出版信息

Z Kardiol. 1994;83 Suppl 6:159-62.

PMID:7863689
Abstract

Antihypertensive therapy improves the long-term prognosis of patients with mild to moderate essential hypertension and is able to prevent complications. This is also true for the elderly patient with hypertension. A considerable percentage of patients with mild essential hypertension can be adequately treated without drugs. If drug treatment is required, diuretics, beta-blockers, calcium antagonists, and ACE-inhibitors are the agents of first choice. For the individual patient, the appropriate drug should be chosen on the basis of efficacy, lack of side-effects, and depending upon additional diseases, such as cardiac failure, coronary heart disease and renal failure. Only if these selection criteria are fulfilled should differences in prices of the various groups of antihypertensive agents be considered.

摘要

抗高血压治疗可改善轻至中度原发性高血压患者的长期预后,并能预防并发症。老年高血压患者亦是如此。相当一部分轻度原发性高血压患者无需药物即可得到充分治疗。如果需要药物治疗,利尿剂、β受体阻滞剂、钙拮抗剂和血管紧张素转换酶抑制剂是首选药物。对于个体患者,应根据疗效、无副作用以及取决于其他疾病,如心力衰竭、冠心病和肾衰竭等情况来选择合适的药物。只有满足这些选择标准时,才应考虑各类抗高血压药物价格上的差异。

相似文献

1
[Cost/benefit relations: therapy of hypertension].[成本/效益关系:高血压治疗]
Z Kardiol. 1994;83 Suppl 6:159-62.
2
Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.轻度至中度原发性舒张期高血压患者初始抗高血压治疗的成本最小化分析。
Clin Ther. 1994 Jan-Feb;16(1):88-102; discussion 87.
3
Antihypertensive drug prescription trends at the primary health care centres in Bahrain.巴林初级卫生保健中心的抗高血压药物处方趋势
Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27. doi: 10.1002/pds.578.
4
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
5
Cost analysis of different pharmacological treatment strategies in elderly hypertensives.老年高血压患者不同药物治疗策略的成本分析
Blood Press. 2005;14(2):107-13. doi: 10.1080/08037050510008940.
6
[Retrospective studies and prospects of therapy for hypertension].[高血压治疗的回顾性研究与展望]
Herz. 1995 Dec;20(6):370-89.
7
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.2004年加拿大高血压管理指南:第二部分——治疗
Can J Cardiol. 2004 Jan;20(1):41-54.
8
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
9
The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment.瑞典高血压治疗的成本效益:干预标准与药物治疗选择的分析
J Hum Hypertens. 1996 Feb;10 Suppl 2:S23-6.
10
Cost-benefit aspects of treatment of hypertension in the elderly.老年人高血压治疗的成本效益方面。
Blood Press Suppl. 1995;3:11-4.